Your browser doesn't support javascript.
loading
Synergic carcinostatic effects of ascorbic acid and hyperthermia on Ehrlich ascites tumor cell.
Saitoh, Y; Yoshimoto, T; Kato, S; Miwa, N.
Affiliation
  • Saitoh Y; Laboratory of Bioscience & Biotechnology for Cell Function Control, Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, 562 Nanatsuka, Shobara, Hiroshima 727-0023, Jap.
  • Yoshimoto T; Laboratory of Bioscience & Biotechnology for Cell Function Control, Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, 562 Nanatsuka, Shobara, Hiroshima 727-0023, Jap.
  • Kato S; Radioisotope Facilities for Medical Science, Life Science Research Center, Mie University, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
  • Miwa N; Department of Radiological Technology, Faculty of Health Sciences, Butsuryo College of Osaka, 3-33 Ohtorikita-machi, Sakai, Osaka 593-8324, Japan.
Exp Oncol ; 37(2): 94-9, 2015 Jun.
Article in En | MEDLINE | ID: mdl-26112934
ABSTRACT

AIM:

In this study, we evaluated the carcinostatic effects of combined ascorbic acid (AsA) and a capacitive-resistive electric transfer (CRet) hyperthermic apparatus-induced hyperthermic treatment on Ehrlich ascites tumor (EAT) cells. MATERIALS AND

METHODS:

EAT cells were exposed to various AsA (0-10 mM) concentrations for 1 h; they subsequently underwent CRet treatment for 15 min at 42 °C. Cell viability was assessed by the WST-8 assay 24 h after the combined treatment. Reactive oxygen species involvement was evaluated using catalase and tempol; caspase-3/7 activation was determined by their fluorescent substrates; cell proliferation were estimated by time-lapse observation. The effect on the cell cycle was analyzed by flow cytometry.

RESULTS:

Combined AsA and CRet treatment synergistically suppressed cell viability compared with either treatment alone, and these synergistically carcinostatic effects were evident even at noncytotoxic concentrations of AsA alone (≤ 2 mM). The carcinostatic effects of combined AsA and CRet treatment were attenuated in a dose-dependent manner by catalase addition, but not by the superoxide anion radical scavenger tempol. Time-lapse observation revealed that combined AsA and CRet treatment activated caspase-3/7 at 10-24 h after treatment, accompanied by significant cell growth suppression. Cell cycle analysis revealed that the rate of sub-G1-phase (apoptotic) cells was drastically increased at 12 h and 24 h, and that the G2/M-phase cells gradually increased at 6-24 h after treatment.

CONCLUSION:

These results indicate that combined AsA and CRet treatment synergistically inhibits EAT cell growth through G2/M arrest and apoptosis induction via H2O2 generation at lower AsA concentrations; this carcinostatic effect cannot be exerted by AsA alone.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ascorbic Acid / Carcinoma, Ehrlich Tumor / Antineoplastic Agents Limits: Animals Language: En Journal: Exp Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ascorbic Acid / Carcinoma, Ehrlich Tumor / Antineoplastic Agents Limits: Animals Language: En Journal: Exp Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article